Health care organizations considering outsourcing sterile compounding services should have a clear understanding of what they want to accomplish. Consideration should include, at the least, an internal needs assessment, a cost analysis, and a careful review of prospective compounding pharmacies. The organization should examine the potential long-term consequences of outsourcing as well as the s...

76. Connor TH, Anderson RW, Sessink PJ et al. Effective-ness of a closed-system device in containing surface contamination with cyclophosphamide and ifosfamidein an i.v. admixture area. Am J Health-Syst Pharm. 2002; 59:68–72.77. Vandenbroucke J, Robays H. How to protect environ-ment and employees against cytotoxic agents: the UZGent experience. J Oncol Pharm Pract. 2001;...

background : inappropriate use of vancomycin not only increase health care costs but also contribute to the emergence of resistant organisms. higher trough serum vancomycin concentrations (>10mg/l) has been recommended for avoidance of development of resistance. we aim to compare the administered dose with recommended doses based on guideline-recommended weight-based dosing. methods : in a cros...

While the ASHP Foundation's annual pharmacy forecast is not intended to be an accurate prediction of future events, it's right on ball for 2021. “We chose focus preparing leaders a ‘black swan’ event,” said Erin Fox, PharmD, BCPS, senior director at University Utah Health. “Who knew that in 2021 we would all facing truly unprecedented year. You can argue COVID-19 wasn’t exactly event as pandemi...

considering the fact that many muslims with diabetes prefer to fast in spite of inhibitory advises and to answer several conflicts and controversies regarding diabetes and ramadan, idf in collaboration with diabetes and ramadan (dar) international in alliance decided to develop a comprehensive guideline to be used by health care professionals. this guideline was then developed on april 2016 by ...

Letter From the Editors W elcome to the 2004 Pharmacy Edition of Frontiers in HematOncology, a report designed to address concerns of the health-system pharmacist. This issue contains a Continuing Education (CE) Program reviewing 2 important symposia—”Prognosis and Treatment of Myelodysplastic Syndromes (MDS),” held at the 2004 Making a Difference in Oncology (MADONC) conference in St Petersbur...

Thank you for the opportunity to be with you today. I am honored to deliver the lecture named for someone I met 21 years ago at a gathering of the Joint Commission of Pharmacy Practitioners (JCPP). I was the executive resident for the American Pharmacists Association, and I was pretty sure I would never again have the chance to sit in the same room as the brain trust of the profession gathered ...

The American Society of Health-System Pharmacists (ASHP) believes that pharmacogenomic testing can improve medication-related outcomes across the continuum of care in all health-system practice settings. These improvements include reduction in suboptimal clinical outcomes, decreased cost of treatment, better medication adherence, more appropriate selection of therapeutic agents, decreased lengt...

For purposes of this document, vendors’ representatives are defined as agents who promote products and provide information and services to health care providers on behalf of manufacturers and suppliers. The narrow focus of this document is on those vendors who serve and interact with settings with respect to drug products, drug-related devices, and other equipment, supplies, and services purcha...

PURPOSE UF Health's participation in a mentored quality-improvement impact program for health professionals as part of an ASHP initiative-"Strategies for Ensuring the Safe Use of Insulin Pens in the Hospital"-is described. SUMMARY ASHP invited hospitals to participate in its initiative at a time when UF Health was evaluating the risks and benefits of insulin pen use due to external reports of...